ARIX BIOSCIENCE PLC ORD 0.001P(ARIX)股吧_ARIX BIOSCIENCE PLC ORD 0.001P怎么样

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
163	0	Scheme Effective	ARIX BIOSCIENCE 资讯	02-12 09:07
85	0	Suspension of Trading in Shares	ARIX BIOSCIENCE 资讯	02-12 04:18
64	0	Transaction Update	ARIX BIOSCIENCE 资讯	02-07 08:33
63	0	Results of First General Meeting	ARIX BIOSCIENCE 资讯	01-29 09:45
124	0	Holding(s) in Company	ARIX BIOSCIENCE 资讯	01-24 12:00
109	0	Holding(s) in Company	ARIX BIOSCIENCE 资讯	01-24 12:00
60	0	Update on the Scheme and Publication of Notice of Second General Meeting	ARIX BIOSCIENCE 资讯	01-23 04:10
59	0	Update on the Scheme and Resignation of Directors	ARIX BIOSCIENCE 资讯	01-22 04:10
67	0	Financial update on Harpoon Therapeutics acquisition by Merck (MSD)	ARIX BIOSCIENCE 资讯	01-19 04:15
65	0	Unaudited NAV for December 2023	ARIX BIOSCIENCE 资讯	01-19 04:14
81	0	Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)	ARIX BIOSCIENCE 资讯	01-09 02:23
61	0	Publication of Circular and RTW Bio Prospectus	ARIX BIOSCIENCE 资讯	01-05 04:06
75	0	Holding(s) in Company	ARIX BIOSCIENCE 资讯	01-05 02:37
81	0	Update regarding timing of Proposed Scheme of Reconstruction	ARIX BIOSCIENCE 资讯	12-22 08:08
75	0	Unaudited NAV for November 2023	ARIX BIOSCIENCE 资讯	12-13 04:21
67	0	Portfolio Company Aura Biosciences Announces First Patient Dosed in Global Phas	ARIX BIOSCIENCE 资讯	12-08 04:10
78	0	Correction: Portfolio Company Aura Biosciences Announces Closing of $99 million	ARIX BIOSCIENCE 资讯	11-14 01:08
66	0	Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offe	ARIX BIOSCIENCE 资讯	11-10 05:07
78	0	PDMR Notification & Director Shareholding	ARIX BIOSCIENCE 资讯	11-10 04:08
63	0	Unaudited NAV for October 2023	ARIX BIOSCIENCE 资讯	11-08 06:15
61	0	PDMR Notification & Director Shareholding	ARIX BIOSCIENCE 资讯	11-04 01:37
70	0	PDMR Notification & Director Shareholding	ARIX BIOSCIENCE 资讯	11-03 03:22
66	0	Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phas	ARIX BIOSCIENCE 资讯	11-02 01:38
79	0	Portfolio company Harpoon Therapeutics announces up to $150 million private pla	ARIX BIOSCIENCE 资讯	10-24 04:45
73	0	Unaudited NAV for September 2023	ARIX BIOSCIENCE 资讯	10-06 03:12
74	0	Interim Results for the Six Months Ended 30 June 2023	ARIX BIOSCIENCE 资讯	09-27 03:11
75	0	Board Change	ARIX BIOSCIENCE 资讯	09-27 03:10
70	0	Notice of Results and Investor Presentation	ARIX BIOSCIENCE 资讯	09-14 03:11
61	0	Unaudited NAV for August 2023	ARIX BIOSCIENCE 资讯	09-14 03:11
94	0	Unaudited NAV for July 2023	ARIX BIOSCIENCE 资讯	08-07 03:05
93	0	Holding(s) in Company	ARIX BIOSCIENCE 资讯	07-17 11:04
77	0	Arix Announces Strategic Review	ARIX BIOSCIENCE 资讯	07-13 03:07
86	0	Unaudited NAV for June 2023	ARIX BIOSCIENCE 资讯	07-13 03:04
92	0	Portfolio company Disc Medicine raises $157.8 million in public offering	ARIX BIOSCIENCE 资讯	06-23 10:15
80	0	Portfolio company Disc Medicine presents positive initial data from Phase 2 BEA	ARIX BIOSCIENCE 资讯	06-09 10:56
87	0	Unaudited NAV for May 2023	ARIX BIOSCIENCE 资讯	06-09 03:13
112	0	Director/PDMR Shareholding	ARIX BIOSCIENCE 资讯	05-31 08:02
103	0	Correction: Result of Annual General Meeting	ARIX BIOSCIENCE 资讯	05-24 03:12
141	0	Result of Annual General Meeting	ARIX BIOSCIENCE 资讯	05-24 12:37
138	0	Portfolio company Ensoma announces closing of Series B Extension	ARIX BIOSCIENCE 资讯	05-17 12:53
121	0	Unaudited NAV for April 2023	ARIX BIOSCIENCE 资讯	05-12 03:09
147	0	Total Voting Rights	ARIX BIOSCIENCE 资讯	05-06 12:36
121	0	Director/PDMR Shareholding	ARIX BIOSCIENCE 资讯	05-05 03:36
105	0	Director/PDMR Shareholding	ARIX BIOSCIENCE 资讯	05-04 08:33
215	0	Director/PDMR Shareholding	ARIX BIOSCIENCE 资讯	05-03 12:05
110	0	Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune	ARIX BIOSCIENCE 资讯	04-27 03:09
112	0	Financial Results for the Year Ended 31 December 2022, Publication of Annual Re	ARIX BIOSCIENCE 资讯	04-25 03:04
119	0	Full Year results now to be released on 25 April 2023	ARIX BIOSCIENCE 资讯	04-19 09:34
106	0	Unaudited NAV for March 2023	ARIX BIOSCIENCE 资讯	04-17 03:07
106	0	Notice of Results and Investor Presentation	ARIX BIOSCIENCE 资讯	04-14 08:03
122	0	Portfolio company Harpoon Therapeutics announces closing of $25 million private	ARIX BIOSCIENCE 资讯	03-28 03:08
214	0	Unaudited NAV for February 2023	ARIX BIOSCIENCE 资讯	03-17 10:12
163	0	Portfolio company Disc Medicine announces $62.5 million financing	ARIX BIOSCIENCE 资讯	02-15 03:40
193	0	Director/PDMR Shareholding	ARIX BIOSCIENCE 资讯	02-07 02:05
169	0	Unaudited NAV for January 2023	ARIX BIOSCIENCE 资讯	02-06 04:20
156	0	Unaudited NAV for December 2022	ARIX BIOSCIENCE 资讯	01-30 04:35
369	0	Board Change	ARIX BIOSCIENCE 资讯	01-26 04:18
143	0	Portfolio company Twelve Bio to be acquired alongside $85 million financing of	ARIX BIOSCIENCE 资讯	01-06 01:38
156	0	Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics	ARIX BIOSCIENCE 资讯	12-30 04:35
136	0	Unaudited NAV for November 2022	ARIX BIOSCIENCE 资讯	12-12 04:37
118	0	Arix to Present at Mello Investment Trusts & Funds	ARIX BIOSCIENCE 资讯	12-06 04:05
109	0	Director/PDMR Shareholding	ARIX BIOSCIENCE 资讯	12-01 04:49
109	0	Unaudited NAV for October 2022	ARIX BIOSCIENCE 资讯	11-09 04:09
147	0	Director/PDMR Shareholding	ARIX BIOSCIENCE 资讯	10-28 03:04
146	0	Holding(s) in Company	ARIX BIOSCIENCE 资讯	10-21 12:48
160	0	Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics	ARIX BIOSCIENCE 资讯	10-14 03:11
131	0	Unaudited NAV for September 2022	ARIX BIOSCIENCE 资讯	10-11 03:11
158	0	Director/PDMR Shareholding	ARIX BIOSCIENCE 资讯	10-05 03:10
173	0	Arix Portfolio Company Aura Biosciences Presents Interim Phase 2 Data Highlight	ARIX BIOSCIENCE 资讯	10-04 12:37
133	0	Unaudited NAV for August 2022	ARIX BIOSCIENCE 资讯	09-15 03:08
129	0	Unaudited NAV for July 2022	ARIX BIOSCIENCE 资讯	08-12 03:10
169	0	Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PA	ARIX BIOSCIENCE 资讯	08-11 02:21
146	0	Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini	ARIX BIOSCIENCE 资讯	08-11 01:52
124	0	Arix Bioscience plc Announces Changes to Board of Directors	ARIX BIOSCIENCE 资讯	08-10 05:23
135	0	Interim Results for the Six Months Ended 30 June 2022	ARIX BIOSCIENCE 资讯	08-10 05:22
122	0	Notice of Results & Investor Presentation	ARIX BIOSCIENCE 资讯	08-03 02:29
153	0	Unaudited NAV for June 2022	ARIX BIOSCIENCE 资讯	07-22 02:16
118	0	Holding(s) in Company	ARIX BIOSCIENCE 资讯	06-23 12:48
124	0	Notice of Investor Presentation	ARIX BIOSCIENCE 资讯	06-22 02:12
156	0	Unaudited NAV for May 2022	ARIX BIOSCIENCE 资讯	06-09 02:26

emytylist